Canopy Growth Partners With NHL Alumni Association For CBD Research

Canadian cannabis company, Canopy Growth Corporation has announced a partnership with the National Hockey League Alumni Association (NHLAA) to research the efficacy of cannabinoids in the treatment of post-concussion neurological diseases in former NHL players.

The Center for Disease Control estimates that there are 1.6 to 3.8 million concussions sustained during sports and recreational activities every year. An estimated 10 to 20 percent those who suffer a traumatic brain injury develop post-concussion syndrome symptoms such as post-traumatic stress disorder or progressive dementia.

“NHL alumni gave everything they had during their careers, but the physical consequences after they hang up their skates can be devastating for both players and their loved ones for the rest of their lives,” said NHLAA Executive director, Glenn Healy. “This study offers the alumni the promise of help and hope, and we are excited to participate in what could become a true game-changer in allowing these professional athletes to finish strong.”

There will be approximately 100 former players participating in the study which will be led by Dr. Amin from NEEKA Health Canada and Dr. Richard Rovin, two neurosurgeons with experience in neuroscience, molecular cell signaling, brain mapping, and clinical trial design.

The majority of the participants will receive cannabidiol (CBD) pills, while a smaller group will get placebos before undergoing a variety of tests which include questionnaires, MRI brain scans, and interactive software that measures speech, writing, memory, and emotional state.

“This complex and multidimensional study will give us an unprecedented understanding of the interaction between cannabidiol and the brains and behaviours of former NHL players living with post-concussion symptoms,” said Canopy Growth Chief Medical Officer, Dr. Mark Ware. “We thank the members of the NHLAA whose willingness to join this unique research partnership speaks to the need for alternative medical treatments to treat the long-term and often devastating effects of concussions.”

The study is to begin sometime during the 2019 summer and will take one year to complete.


  1. Ashtonford March 3, 2019
  2. Eddie Jay March 5, 2019